RA
Pharmacist Interventions Can Help With RA Nonadherence
Identifying patients with rheumatoid arthritis who may be at risk of nonadherence to treatment, and targeting them ...
JANUARY 13, 2025
Helping RA Patients Cope With Pain, Anxiety and Depression
Rheumatoid arthritis can have psychosocial impacts such as anxiety, depression, physical inactivity, fatigue, ...
DECEMBER 18, 2024
Health Literacy Screening May Be Helpful for Personalizing RA Care
Incorporating the use of the Brief Health Literacy Screening tool into the management of patients with rheumatoid ...
DECEMBER 9, 2024
2 Genes Common in RA and Osteoporosis
Two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential ...
DECEMBER 5, 2024
Taking the RA Threat to Heart During Pregnancy
Obesity, gestational diabetes mellitus and acute cardiovascular complications are more common among pregnant women ...
DECEMBER 2, 2024
RA Assessment Confirms Remission, Not Causes of Ongoing Pain
The Routine Assessment of Patient Index Data 3 identifies patients in remission. However, RAPID3’s utility is ...
NOVEMBER 13, 2024
Couples Who Cope With RA Together Stay Together
When couples in which one of the partners has rheumatoid arthritis cope with the condition together, they ...
NOVEMBER 8, 2024
Self-Management Strategies Improve Quality of Life for Rheumatic Disease Patients
Making healthier choices, as well as being adherent to prescribed medications, can improve the quality of life of ...
NOVEMBER 7, 2024
RA Is a Risk Factor for Long COVID in Older Individuals
Older adults are more susceptible to COVID-19 complications, especially those with pre-existing conditions such as ...
OCTOBER 4, 2024
Some People With RA Have Pain Without Inflammation
Some patients with RA have a suite of 815 genes that activate abnormal growth of sensory neurons in tissues that ...
OCTOBER 3, 2024
Rheumatoid Arthritis and Safe Conception and Pregnancy
People with RA who are trying to conceive have many questions, and it is important to offer advice about how to ...
OCTOBER 1, 2024
Biosimilar Approved to Treat Moderate to Severe RA
The FDA has approved rituximab-arrx for adults with moderate to severe active RA.
JUNE 8, 2022
